RhAPPcast :The Clinical Utility of Guselkumab in Axial PsA

Host Amanda Mixon, President of RhAPP, is joined by Audrey Gibson, a Physician Assistant and fellow RhAPP member. They explore the clinical utility of guselkumab for treating axial psoriatic arthritis, a topic gaining significant interest in the rheumatology community.

Audrey shares insights from key clinical trials and offers practical advice on using IL-23 inhibitors in clinical practice. Whether you’re an experienced practitioner or new to the field, this discussion will enhance your understanding of the evolving treatment landscape.